Worldwide Healthcare News

O torhinolaryngology devices industry was pegged at $9.26 billion in 2018, and is expected to reach $13.99 billion by 2026, registering a CAGR of 5.2% from 2019 to 2026. Request Sample Report at:  https://www.alliedmarketresearch.com/request-sample/6400 Incentives for market growth High prevalence of chronic sinusitis, increase in adoption of minimally invasive ENT procedures, and rise in elderly population drive the growth of the global otorhinolaryngology devices market. However, limited awareness and high costs, and government regulations and reimbursement issues hamper the growth to certain extent. On the contrary, high growth prospects in emerging market would open new opportunities for the market players. The diagnostic devices segment dominated the market The diagnostic devices segment held the largest share in 2019, accounting for nearly one-third of the global otorhinolaryngology devices market, due to use of ENT endoscopes, hearing screening device, La...

  cell therapy processing industry garnered $1.69 billion in 2018, and is estimated to reach $12.06 billion by 2026, growing at a CAGR of 27.8% from 2019 to 2026. Prime determinants of growth Increase in the incidence of cardiovascular diseases and surge in the demand for chimeric antigen receptor (CAR) cell therapy propel the global cell therapy processing market. However, poor demand from underdeveloped countries hinders the market growth. On the other hand, emerging markets are expected offer lucrative opportunities in the near future. Request Sample Report at  https://www.alliedmarketresearch.com/request-sample/6446 The products segment to maintain its leadership position by 2026 Based on offering type, the products segment contributed to more than four-fifths of the total share of the global cell therapy processing market in 2018, and is expected to maintain its leadership position throughout the forecast period. This is due to the extensive use of con...

  The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape. For Right Perspective and Competitive Insights, Get Sample Report at:  https://www.alliedmarketresearch.com/request-sample/5093 Increase in obesity worldwide, rise in aesthetic consciousness, and advancements in the field of body contouring facilitate the growth in the market. However, high cost related to body contouring procedures restrains market growth. On the other hand, the increase in medical tourism and untapped potential in emerging economies create new opportunities. Comprehensive competitive analysis and profiles of major market players, such as Leading market players analyzed in the report include Allergan plc, Bausch Health Companies Inc., Hologic, Inc., Shanghai Fosun Pharmaceutical Group Co., Ltd., Erchonia Corporation, MicroAire Surgical Instruments, LLC, Cutera, Inc., InMode Aesthetic Solutions,...

  The  antihypertensive drugs industry  was pegged at $22.56 billion in 2018, and is estimated to reach $28.79 billion by 2026, growing at a CAGR of 3.1% from 2019 to 2026. The report provides an extensive analysis of the market dynamics including drivers & restraints, major winning strategies, market size & projections, competitive landscape, and major segments. Request Sample Report at:   https://www.alliedmarketresearch.com/request-sample/436 Increase in geriatric population worldwide, rise in healthcare expenditure worldwide, and surge in prevalence of hypertension across the globe have augmented the growth of the global antihypertensive drugs market. Whereas, patent expirations of blockbuster drugs impede the market growth. On the other hand, high growth potential in developing economies is projected to provide lucrative opportunities in the near future. The global antihypertensive drugs market size is categorized on the basis of therapeutic class, distr...

Telemedicine/Telehealth Market to Hit $431.82 Bn, Globally, by 2030 at 25.90% CAGR: Allied Market Research : /PRNewswire/ -- Allied Market Research recently published a report, titled, "Telemedicine market by Application (Teleradiology, Telepsychiatry, Telepathology,...

  Rise in incidence of sports-related injuries, supportive government initiatives, and increase in awareness about physical fitness are anticipated toboost the growth of the global sports medicine devices market.   The report offers an extensive analysis of the changing trends, key market segments, drivers and opportunities, competitive landscape, top investment pockets among others. According to the report, the global  sports medicine devices market  accrued $7.17 billion in 2017 and is expected to reach $12.73 billion by 2025, growing at a CAGR of 7.3% from 2018 to 2025. Rise in incidence of sports-related injuries, increase in awareness about physical fitness, and supportive government initiatives drive the growth of the industry. However, dearth of skilled professionals and lack of guidance on appropriate administration of sports medicines hinder the market growth. On the other hand, surge in demand for minim...

The report provides detailed analyses of the top winning strategies, market share & estimations, driving factors & opportunities, key market segments, and competitive landscape. As per the report, the global   dental consumables market   was pegged at $41.06 billion in 2017 and is expected to garner $55.58 billion by 2023, growing at a CAGR of 5.2% through 2023. High prevalence of dental diseases among geriatric population, surge in dental tourism across emerging economies, and increase in demand for minimally invasive dental procedures drive the growth of the global dental consumables market. Moreover, increase in awareness about oral hygiene supplements the market growth. However, high cost of dental products along with very limited reimbursement hampers the growth of the market. On the contrary, rise in demand for dental cosmetic procedures and increase in awareness about proper dentition are expected to provide lucrative opportunities for t...

  Surgical navigation systems market   was valued at $628 million in 2015, and is projected to reach $963 million by 2022, growing at a CAGR of 6.3% from 2016 to 2022, according to a new report published by Allied Market Research. Optical navigation systems segment is expected to grow at the highest growth rate during the forecast period, owing to benefits such as minimum radiation exposure and preciseness & accuracy during complex surgeries. The major factors that drive the growth of this market include rise in adoption of minimal invasive surgeries, improvement in healthcare infrastructure in emerging economies, numerous technological advancements, increase in incidence of ENT and neurosurgery-related disorders, and growth in knee replacement surgeries globally. However, high cost of these systems and stringent FDA rules are the major barriers that restrain the market growth. Get access to detailed report at:   https://www.alliedmarketresearch.co...

The   radiology information system market   was valued at $603 million in 2015, and is projected to reach $941 million by 2022, growing at a CAGR of 5.9% from 2016 to 2022. The integrated radiology information systems segment held over three-fifths share of the total market in 2015. Radiology information system (RIS) is a computer networked system used to organize and manage the workflow of medical imagery and radiology department, supporting business analysis in a department. RIS is widely used along with picture archiving and communication system (PACS) and vendor neutral archive to manage billing, record keeping, and image archives. The integrated radiology information systems held the largest share in 2015 and is expected to grow at the highest CAGR of 6.0% during the analysis period. This is owing to the surging adoption and demand of integrated healthcare information technology platforms in various healthcare organization for easy operations to curb o...

  Global  Meningococcal Vaccine Industry  garnered $1.93 billion in 2018, and is projected to garner $4.19 billion by 2026, witnessing a CAGR of 9.5% from 2019 to 2026. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. Prime determinants of growth Rise in outbreaks of meningococcal disease, increase in immunization programs across the world, and surge in research and development for vaccine technology drive the global meningococcal vaccine market. However, long duration required for vaccine production and high cost of vaccine development hinder the market growth. On the other hand, increase in healthcare expenditure and untapped potential in emerging economies create new opportunities in the coming years. Covid-19 scenario: The global lockdown has paused the immunization programs. However, in certain regions the progra...